Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Nimodipine - Generic Drug Details

« Back to Dashboard

What are the generic sources for nimodipine and what is the scope of nimodipine patent protection?

Nimodipine
is the generic ingredient in three branded drugs marketed by Thepharmanetwork Llc, Heritage Pharms Inc, Sofgen Pharms, Bionpharma Inc, Arbor Pharms Llc, Sun Pharm Inds Inc, and Bayer Pharms, and is included in seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for nimodipine. Ten suppliers are listed for this compound.

Summary for Generic Name: nimodipine

Tradenames:3
Patents:1
Applicants:7
NDAs:7
Drug Master File Entries: see list7
Suppliers / Packagers: see list10
Bulk Api Vendors: see list66
Clinical Trials: see list10
Patent Applications: see list7,645
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:nimodipine at DailyMed

Pharmacology for Ingredient: nimodipine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc
NIMODIPINE
nimodipine
CAPSULE;ORAL077067-001Apr 17, 2007ABRXNoNo► Subscribe► Subscribe
Bionpharma Inc
NIMODIPINE
nimodipine
CAPSULE;ORAL076740-001Jan 17, 2008ABRXNoYes► Subscribe► Subscribe
Arbor Pharms Llc
NYMALIZE
nimodipine
SOLUTION;ORAL203340-001May 10, 2013RXYesYes► Subscribe► Subscribe
Heritage Pharms Inc
NIMODIPINE
nimodipine
CAPSULE;ORAL077811-001May 2, 2007ABRXNoNo► Subscribe► Subscribe
Sofgen Pharms
NIMODIPINE
nimodipine
CAPSULE;ORAL201832-001Jul 24, 2015ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot